AN2 Therapeutics to participate in three upcoming investor conferences

ANTX•2026-10-20

AN2 Therapeutics will attend three healthcare conferences in November 2026, where CEO Eric Easom will take part in a fireside chat and present a corporate overview, and management will hold one-on-one meetings.

1. November conferences

AN2 Therapeutics will attend the Guggenheim 3rd Annual Healthcare Innovation Conference on Nov. 9-11, the Stifel 2026 Healthcare Conference on Nov. 10-12 and the Jefferies London Conference on Nov. 16-19. CEO Eric Easom will join a fireside chat on Nov. 9 at 9:30 a.m. ET and present a corporate overview on Nov. 10 at 8:40 a.m. ET. Management will be available for one-on-one meetings at all three conferences, including Nov. 17 at the Jefferies conference.

AN2 Therapeutics to participate in three upcoming investor conferences

1. November conferences

Related News

M&T Bank declares quarterly dividend of $0.3515625 per Series H preferred share

Claros Mortgage Trust publishes update to financial calendar

M&T Bank vice chairman Kevin J. Pearson reports sale of $441,500 in common shares

Alcon acquires Neurotech for $550 million

Parker Hannifin publishes update to financial calendar